comparemela.com

Latest Breaking News On - Pharmaceuticals stock performance - Page 4 : comparemela.com

Mizuho Cuts ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $21.00

Mizuho Cuts ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target to $21.00
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United-states
Canada
America
Brendan-teehan
Stephen-davis
Pharmaceuticals-stock-performance
Acadia-pharmaceuticals
Needham-company
Charles-schwab-investment-management-inc
Qube-research-technologies-ltd
Securities-exchange-commission
Northern-trust-corp

ACADIA Pharmaceuticals (NASDAQ:ACAD) Posts Earnings Results, Beats Expectations By $0.06 EPS

ACADIA Pharmaceuticals (NASDAQ:ACAD) Posts Earnings Results, Beats Expectations By $0.06 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United-states
James-kihara
Brendan-teehan
Robertw-baird
Pharmaceuticals-inc
Pharmaceuticals-daily
Acadia-pharmaceuticals
Needham-company
Pharmaceuticals-stock-performance
Cantor-fitzgerald
Get-free-report

scPharmaceuticals (SCPH) to Release Quarterly Earnings on Tuesday

scPharmaceuticals (SCPH) to Release Quarterly Earnings on Tuesday
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Pharmaceuticals-stock-performance
Pharmaceuticals-inc
Pharmaceuticals-daily
Get-free-report
Pharmaceuticals-stock
Body-infusor

Citigroup Lowers ORIC Pharmaceuticals (NASDAQ:ORIC) Price Target to $14.00

Citigroup Lowers ORIC Pharmaceuticals (NASDAQ:ORIC) Price Target to $14.00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Monaco
United-states
Jpmorgan-chase-co
Sherbrooke-park-advisers
Algert-global
Vivo-capital
Jump-financial
Pharmaceuticals-inc
Oric-pharmaceuticals
Cantor-fitzgerald
Citigroup

X4 Pharmaceuticals (NASDAQ:XFOR) Price Target Increased to $5.00 by Analysts at HC Wainwright

X4 Pharmaceuticals (NASDAQ:XFOR – Get Free Report) had its target price lifted by equities researchers at HC Wainwright from $3.00 to $5.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price target points to a potential upside of 352.49% from the company’s […]

Paula-ragan
Adams-mostafa
Securities-exchange-commission
Pharmaceuticals-stock-performance
Capital-partners
Pharmaceuticals-company-profile
Pharmaceuticals-daily
Stonepine-capital-management
Pharmaceuticals-inc
Bain-capital-life-sciences-investors
Sg-americas-securities
Get-free-report

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.